Figure (Nat07 0000 01)
Natesto
Product Images NDC 69654-239
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 14 technical images submitted to the FDA as part of the official labeling for Natesto (NDC 69654-239). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Aytu Bioscience, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Figure (Nat07 0000 02)
Figure (Nat07 0000 03)
Figure (Nat07 0000 04)
Figure 1 (Nat07 0000 05)
Figure A (Nat07 0000 06)
Figure B (Nat07 0000 07)
Figure C (Nat07 0000 08)
Figure D (Nat07 0000 09)
Figure E (Nat07 0000 10)
Figure F (Nat07 0000 11)
Figure G (Nat07 0000 12)
Figure H (Nat07 0000 13)
Principal Display Panel (Natesto Nasal Gel Carton)
This is a description of a testosterone nasal gel marketed under the name Natesto. It contains 5.5mg of testosterone per actuation, and each actuation delivers 0.122 g of the gel. It is intended for intranasal use only, and the package is not child-resistant. The total contents of each dispenser are 11g. The active ingredient is testosterone, USP, and the inactive ingredients include Castor Ol, Oleoyl Polyoxylgycerides, Collodial Silicon Dioxide. It is manufactured by Haupt Pharma Amareg GmbH in Regensburg, Bavaria, Germany and is marketed by Aytu BioScience, Inc. in Englewood, Colorado. The text contains some errors and some of the text is not available.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
